GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (FRA:SBS) » Definitions » Cyclically Adjusted PB Ratio

Stratec SE (FRA:SBS) Cyclically Adjusted PB Ratio : 3.00 (As of Jun. 10, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Stratec SE Cyclically Adjusted PB Ratio?

As of today (2024-06-10), Stratec SE's current share price is €46.30. Stratec SE's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €15.45. Stratec SE's Cyclically Adjusted PB Ratio for today is 3.00.

The historical rank and industry rank for Stratec SE's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:SBS' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.37   Med: 6.87   Max: 12.7
Current: 2.99

During the past years, Stratec SE's highest Cyclically Adjusted PB Ratio was 12.70. The lowest was 2.37. And the median was 6.87.

FRA:SBS's Cyclically Adjusted PB Ratio is ranked worse than
65.05% of 475 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs FRA:SBS: 2.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Stratec SE's adjusted book value per share data for the three months ended in Mar. 2024 was €18.856. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €15.45 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Stratec SE Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Stratec SE's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE Cyclically Adjusted PB Ratio Chart

Stratec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.05 11.41 11.34 5.77 2.94

Stratec SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.27 4.24 2.89 2.94 2.54

Competitive Comparison of Stratec SE's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Stratec SE's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stratec SE's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Stratec SE's Cyclically Adjusted PB Ratio falls into.



Stratec SE Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Stratec SE's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=46.30/15.45
=3.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stratec SE's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Stratec SE's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=18.856/125.0381*125.0381
=18.856

Current CPI (Mar. 2024) = 125.0381.

Stratec SE Quarterly Data

Book Value per Share CPI Adj_Book
201406 8.504 99.543 10.682
201409 9.006 99.823 11.281
201412 9.509 99.543 11.945
201503 10.222 99.717 12.818
201506 9.996 100.417 12.447
201509 10.456 100.417 13.020
201512 10.917 99.717 13.689
201603 0.000 100.017 0.000
201606 10.901 100.717 13.533
201609 11.129 101.017 13.775
201612 12.008 101.217 14.834
201703 12.477 101.417 15.383
201706 11.867 102.117 14.531
201709 12.458 102.717 15.165
201712 13.246 102.617 16.140
201803 13.048 102.917 15.853
201806 11.925 104.017 14.335
201809 12.326 104.718 14.718
201812 12.722 104.217 15.264
201903 12.807 104.217 15.366
201906 12.373 105.718 14.634
201909 12.533 106.018 14.782
201912 13.223 105.818 15.625
202003 13.109 105.718 15.505
202006 13.022 106.618 15.272
202009 13.412 105.818 15.848
202012 14.261 105.518 16.899
202103 15.114 107.518 17.577
202106 15.607 108.486 17.988
202109 16.468 109.435 18.816
202112 16.968 110.384 19.221
202203 17.940 113.968 19.683
202206 16.852 115.760 18.203
202209 17.652 118.818 18.576
202212 18.525 119.345 19.409
202303 18.929 122.402 19.337
202306 18.303 123.140 18.585
202309 18.579 124.195 18.705
202312 19.194 123.773 19.390
202403 18.856 125.038 18.856

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stratec SE  (FRA:SBS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Stratec SE Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Stratec SE's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stratec SE (FRA:SBS) Business Description

Traded in Other Exchanges
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.